These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31051151)

  • 21. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF.
    Sanders-van Wijk S; Muzzarelli S; Neuhaus M; Kiencke S; Maeder M; Estlinbaum W; Tobler D; Mayer K; Erne P; Pfisterer ME; Brunner-La Rocca HP;
    Eur J Heart Fail; 2013 Aug; 15(8):910-8. PubMed ID: 23666681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF.
    Biegus J; Mebazaa A; Davison B; Cotter G; Edwards C; Čelutkienė J; Chioncel O; Cohen-Solal A; Filippatos G; Novosadova M; Sliwa K; Adamo M; Arrigo M; Lam CSP; Ter Maaten JM; Deniau B; Barros M; Čerlinskaitė-Bajorė K; Damasceno A; Diaz R; Gayat E; Kimmoun A; Pang PS; Pagnesi M; Saidu H; Takagi K; Tomasoni D; Voors AA; Metra M; Ponikowski P
    J Am Coll Cardiol; 2024 Jul; 84(4):323-336. PubMed ID: 39019527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial.
    Huijts M; van Oostenbrugge RJ; Duits A; Burkard T; Muzzarelli S; Maeder MT; Schindler R; Pfisterer ME; Brunner-La Rocca HP;
    Eur J Heart Fail; 2013 Jun; 15(6):699-707. PubMed ID: 23384944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlations between serum intact parathyroid hormone (PTH) and N-terminal-probrain natriuretic peptide levels in elderly patients with chronic heart failure (CHF).
    Zhang S; Hu Y; Zhou L; Chen X; Wang Y; Wu J; He H; Gao Y
    Arch Gerontol Geriatr; 2015; 60(2):359-65. PubMed ID: 25466512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial.
    Butler J; Anstrom KJ; Felker GM; Givertz MM; Kalogeropoulos AP; Konstam MA; Mann DL; Margulies KB; McNulty SE; Mentz RJ; Redfield MM; Tang WHW; Whellan DJ; Shah M; Desvigne-Nickens P; Hernandez AF; Braunwald E;
    JAMA Cardiol; 2017 Sep; 2(9):950-958. PubMed ID: 28700781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure.
    Patel RB; Vaduganathan M; Rikhi A; Chakraborty H; Greene SJ; Hernandez AF; Felker GM; Redfield MM; Butler J; Shah SJ
    JACC Heart Fail; 2019 Jan; 7(1):47-55. PubMed ID: 30409707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial.
    Ambrosy AP; Pang PS; Khan S; Konstam MA; Fonarow GC; Traver B; Maggioni AP; Cook T; Swedberg K; Burnett JC; Grinfeld L; Udelson JE; Zannad F; Gheorghiade M;
    Eur Heart J; 2013 Mar; 34(11):835-43. PubMed ID: 23293303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single BNP measurement in acute heart failure does not reflect the degree of congestion.
    Omar HR; Guglin M
    J Crit Care; 2016 Jun; 33():262-5. PubMed ID: 27040515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis of acute heart failure based on clinical data of congestion.
    Espinosa B; Llorens P; Gil V; Rossello X; Jacob J; Herrero P; Martín-Sánchez FJ; Alquézar-Arbé A; Masip J; Miró Ò;
    Rev Clin Esp (Barc); 2022; 222(6):321-331. PubMed ID: 34756646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-type natriuretic peptide. Guided vs. conventional care in outpatients with chronic heart failure: a retrospective study.
    De Vecchis R; Esposito C; Di Biase G; Ariano C
    Minerva Cardioangiol; 2013 Aug; 61(4):437-49. PubMed ID: 23846010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma Corin as a Predictor of Cardiovascular Events in Patients With Chronic Heart Failure.
    Zhou X; Chen JC; Liu Y; Yang H; Du K; Kong Y; Xu XH
    JACC Heart Fail; 2016 Aug; 4(8):664-9. PubMed ID: 27179834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure.
    Lucas C; Johnson W; Hamilton MA; Fonarow GC; Woo MA; Flavell CM; Creaser JA; Stevenson LW
    Am Heart J; 2000 Dec; 140(6):840-7. PubMed ID: 11099986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure.
    Pellicori P; Shah P; Cuthbert J; Urbinati A; Zhang J; Kallvikbacka-Bennett A; Clark AL; Cleland JGF
    Eur J Heart Fail; 2019 Jul; 21(7):904-916. PubMed ID: 30666769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extremely elevated BNP in acute heart failure: Patient characteristics and outcomes.
    Omar HR; Guglin M
    Int J Cardiol; 2016 Sep; 218():120-125. PubMed ID: 27232923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial.
    Mecklai A; Subačius H; Konstam MA; Gheorghiade M; Butler J; Ambrosy AP; Katz SD
    JACC Heart Fail; 2016 Jul; 4(7):580-588. PubMed ID: 27039131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comprehensive assessment of congestion in heart failure].
    Ricarte-Bratti JP; Lozita J; Ravinovich E
    Medicina (B Aires); 2023; 83(6):939-947. PubMed ID: 38117713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loop diuretics in chronic heart failure: how to manage congestion?
    Simonavičius J; Knackstedt C; Brunner-La Rocca HP
    Heart Fail Rev; 2019 Jan; 24(1):17-30. PubMed ID: 30194516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different trajectories and significance of B-type natriuretic peptide, congestion and acute kidney injury in patients with heart failure.
    Beltrami M; Ruocco G; Ibrahim A; Lucani B; Franci B; Nuti R; Palazzuoli A
    Intern Emerg Med; 2017 Aug; 12(5):593-603. PubMed ID: 28181125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.